Noveris Health Sciences announced its annual general meeting (AGM) will be held on September 4, 2026, with a record date of July 21, 2026. Shareholders will vote on director elections, auditor appointments, and other business. The company must also prove compliance with Canadian Securities Exchange (CSE) listing requirements by the end of September 2026 to avoid an inactive status on its shares. Management is actively working to meet these requirements and encourages shareholders to review meeting materials and vote in advance.
Man Group PLC has disclosed a 5.9% interest in Vesuvius plc, including 13.7 million ordinary shares and cash-settled derivatives. The disclosure also reveals a recent sale of 131,452 shares at £4.6447 each. This public filing under the UK Takeover Co...
Cliq, a payments technology company, has signed a multi-year deal to become a third-party payment processor for Vast Bank, a nationally chartered U.S. bank. This partnership enables Cliq’s clients, including merchants and software vendors, to access ...
The global shape memory alloys market is projected to grow from $17.14 billion in 2025 to $31.97 billion by 2031, at a CAGR of 11.23%. Growth is fueled by rising demand in minimally invasive medical devices, electric vehicle components, aerospace wei...
The global femtech market, valued at $66.2 billion in 2025, is projected to grow at a CAGR of 14.9% to reach $255.5 billion by 2035. Growth is fueled by digital technology integration in women's health, including AI, telehealth, and wearable devices,...
A new report reveals the AI in catalyst development market is projected to grow from $2.29 billion in 2025 to $28 billion by 2034, driven by innovations in AI-based catalyst design and process optimization. The US and China dominate patent filings, w...
